Literature DB >> 24370247

Feasibility and reproducibility of echocardiographic assessment of regional left atrial deformation and synchrony by tissue Doppler ultrasonographic imaging in healthy dogs.

Marco Baron Toaldo1, Carlo Guglielmini, Alessia Diana, Fabio Sarcinella, Mario Cipone.   

Abstract

OBJECTIVE: To assess the feasibility and reproducibility of longitudinal tissue Doppler ultrasonographic imaging with regard to determination of velocity, strain, and strain rate (SR) of the left atrium (LA) and use those data to characterize LA synchrony (LAS) for a group of healthy dogs. ANIMALS: 15 healthy dogs. PROCEDURES: For each dog, apical 4- and 2-chamber echocardiographic views were obtained. Peak velocity, strain, and SR and time to peak value during systole, early diastole, and late diastole were measured for each of the 4 LA walls. To characterize LAS, mean and SD maximal late diastolic time difference (LAD) among the 4 walls were calculated on the basis of time to peak for velocity, strain, and SR; for each, the 95% confidence interval (mean ± 2SD) was calculated. Within-day and between-day intraobserver variability was calculated.
RESULTS: For all dogs, tissue velocity and SR had peak positive values during systole and 2 negative peaks during early and late diastole. Atrial strain had a peak positive value during systole, positive values during early diastole, and a negative peak value during late diastole. Reproducibility was acceptable for most variables. Diastolic strain and SR had the highest variability, but times to peak values were always reproducible. For velocity, strain, and SR, the 95% confidence interval for the maximal LAD was < 50 milliseconds and that for the SD of the LAD was < 23 milliseconds. CONCLUSIONS AND CLINICAL RELEVANCE: Longitudinal tissue Doppler imaging of LA deformation was feasible in healthy dogs, and its application may be useful for understanding atrial pathophysiologic changes associated with various cardiac diseases in dogs.

Entities:  

Mesh:

Year:  2014        PMID: 24370247     DOI: 10.2460/ajvr.75.1.59

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  6 in total

1.  Assessment of Left Atrial Deformation and Function by 2-Dimensional Speckle Tracking Echocardiography in Healthy Dogs and Dogs With Myxomatous Mitral Valve Disease.

Authors:  M Baron Toaldo; G Romito; C Guglielmini; A Diana; N G Pelle; B Contiero; M Cipone
Journal:  J Vet Intern Med       Date:  2017-04-28       Impact factor: 3.333

2.  Left Atrial Strain at Different Stages of Myxomatous Mitral Valve Disease in Dogs.

Authors:  K Nakamura; S Kawamoto; T Osuga; T Morita; N Sasaki; K Morishita; H Ohta; M Takiguchi
Journal:  J Vet Intern Med       Date:  2017-02-01       Impact factor: 3.333

3.  Prognostic value of echocardiographic indices of left atrial morphology and function in dogs with myxomatous mitral valve disease.

Authors:  Marco Baron Toaldo; Giovanni Romito; Carlo Guglielmini; Alessia Diana; Nazzareno G Pelle; Barbara Contiero; Mario Cipone
Journal:  J Vet Intern Med       Date:  2018-03-23       Impact factor: 3.333

4.  Echocardiographic Findings in Canine Model of Chagas Disease Immunized with DNA Trypanosoma cruzi Genes.

Authors:  Olivia Rodríguez-Morales; Francisco-Javier Roldán; Jesús Vargas-Barrón; Enrique Parra-Benítez; María de Lourdes Medina-García; Emilia Vergara-Bello; Minerva Arce-Fonseca
Journal:  Animals (Basel)       Date:  2020-04-09       Impact factor: 2.752

5.  Effect of pimobendan on left atrial function in dogs with preclinical myxomatous mitral valve disease.

Authors:  Fabio Sarcinella; Joao Neves; Thomas W Maddox; Hannah M Hodgkiss-Geere; Elizabeth F Bode; Joanna Dukes-McEwan
Journal:  Open Vet J       Date:  2019-12-31

6.  Echocardiographic predictors of first onset of atrial fibrillation in dogs with myxomatous mitral valve disease.

Authors:  Marco Baron Toaldo; Chiara Mazzoldi; Giovanni Romito; Helen Poser; Barbara Contiero; Mario Cipone; Carlo Guglielmini
Journal:  J Vet Intern Med       Date:  2020-08-07       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.